α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Rubicon-regulated beta-1 adrenergic receptor recycling protects the heart from pressure overload

Targeting of G-protein coupled receptors in sepsis - ScienceDirect

Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia - ScienceDirect

What Is the Role of β-Adrenergic Signaling in Heart Failure?

Drugs and Toxins - ScienceDirect

IJMS, Free Full-Text

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

Frontiers Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis

Quantitative Determination of Endoplasmic Reticulum Viscosity during Immunogenic Cell Death by a Theranostic Rhenium Complex

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Arrhythmogenic Remodeling of β2 Versus β1 Adrenergic Signaling in the Human Failing Heart

Drugs and Toxins - ScienceDirect

Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis

Labetalol - an overview